Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion
OrthoSpineNews
MARCH 10, 2025
Dr. Steven Anagnost, an orthopedic surgeon at Oklahoma Spine and Musculoskeletal Medicine, echoed this optimism: The impact of the REFINE study cannot be overstated. Contact: Aurora Spine Corporation Trent Northcutt President and Chief Executive Officer (760) 424-2004 Chad Clouse Chief Financial Officer (760) 424-2004 www.aurora-spine.com
52 
Let's personalize your content